Effects of vildagliptin added to pioglitazone or glimepiride in poorly controlled type 2 diabetic patients.
Phase of Trial: Phase II
Latest Information Update: 13 May 2014
At a glance
- Drugs Vildagliptin (Primary) ; Glimepiride; Pioglitazone
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 13 May 2014 Results published in the Diabetic Medicine.
- 05 Nov 2010 New trial record.
- 29 Sep 2009 Results presented at the 45th Annual Meeting of the European Association for the Study of Diabetes.